1 year return (CAGR)
2.41%
BeiGene Ltd Exchange (NASDAQ, USD)
BGNE
-
+0.90 (+0.49%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-11.96%
5 year return (CAGR)
2.01%
10 year return (CAGR)
-
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
18.04B
Price/Sales
5.44
Ent value
17.73B
Price/Book
5.25
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-7.02%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
No data
Stock price data
| Open | 184.00 |
| Daily high | 187.42 |
| Daily low | 183.91 |
| Daily Volume | 332K |
| 1y analyst estimate | 280.92 |
| Beta | 0.63 |
| EPS (TTM) | -8.12 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| BGNE | S&P500 | |
| Current price drop from All-time high | -54.18% | -3.58% |
| Highest price drop | -69.96% | -56.47% |
| Date of highest drop | 11 May 2022 | 9 Mar 2009 |
| Avg drop from high | -29.83% | -10.68% |
| Avg time to new high | 25 days | 12 days |
| Max time to new high | 827 days | 1805 days |
News
No items found